Compelling evidence has shown that lncRNAs are aberrantly expressed in AD progression and modulate beta amyloid beta (Aβ) peptide formation, Tau hyperphosphorylation, neuroinflammation, and neuronal apoptosis [26,27]. Here, MAPT is linked to Alzheimer disease.